Falsification Testing of Instrumental Variables Methods for Comparative Effectiveness Research

Health Services Research

Volumn 51, Issue 2, 2016, Pages 790-811

  Pizer, Steven D ^a  

^a NONE   (United States)

Author keywords

big data; causal inference; Comparative effectiveness research; falsification testing; instrumental variables

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; SULFONYLUREA; ANTIDIABETIC AGENT;

AGED; ANALYTIC METHOD; ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; FALSIFICATION TESTING; FEMALE; HOSPITALIZATION; HUMAN; INSTRUMENTAL VARIABLE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; METHODOLOGY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; RISK ASSESSMENT; CLINICAL PRACTICE; DIABETES MELLITUS, TYPE 2; PROCEDURES; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

COMPARATIVE EFFECTIVENESS RESEARCH; DIABETES MELLITUS, TYPE 2; HOSPITALIZATION; HUMANS; HYPOGLYCEMIC AGENTS; MODELS, STATISTICAL; PRACTICE PATTERNS, PHYSICIANS'; RESEARCH DESIGN;

EID: 84939826173     PISSN: 00179124     EISSN: 14756773     Source Type: Journal    
DOI: 10.1111/1475-6773.12355     Document Type: Article

References (54)

1. Action to Control Cardiovascular Risk in Diabetes Study (ACCORD) Group. 2008. " Effects of Intensive Glucose Lowering in Type 2 Diabetes." New England Journal of Medicine 358: 2545-59.
2. AHRQ. 2001. AHRQ Quality Indicators-Guide to Prevention Quality Indicators: Hospital Admission for Ambulatory Care Sensitive Conditions. AHRQ Pub. No. 02-R0203. Rockville, MD: Agency for Healthcare Research and Quality.
3. Agency for Health Care Research and Quality [AHRQ]. 2013. " Prevention Quality Indicators Technical Specifications-Version 4.5 " [accessed on August 1, 2013]. Available at http://www.qualityindicators.ahrq.gov/Modules/PQI-TechSpec.aspx
4. Alexander, G. C., N. L. Sehgal, R. M. Moloney, and, R. S. Stafford,. 2008. " National Trends in Treatment of Type 2 Diabetes Mellitus, 1994-2007." Archives of Internal Medicine 168: 2088-94.
5. Arnold, N., M. W. Sohn, C. Maynard, and, D. M. Hynes,. 2006. VIReC Technical Report 2: VA Mortality Data Merge Project. Hines, IL: VA Information Resource Center.
6. Bartel, A. P., C. W. Chan, and, S. H. Kim,. 2014. Should Hospitals Keep Their Patients Longer? The Role of Inpatient and Outpatient Care in Reducing Readmissions. NBER Working Paper# 20499. Cambridge, MA: National Bureau of Economic Research.
7. Bennett, W. L., N. M. Maruthur, S. Singh, J. B. Segal, L. M. Wilson, R. Chatterjee, S. S. Marinopoulos, M. A. Puhan, P. Ranasinghe, L. Block, W. K. Nicholson, S. Hutfless, E. B. Bass, and, S. Bolen,. 2011. " Comparative Effectiveness and Safety of Medications for Type 2 Diabetes: An Update Including New Drugs and 2-Drug Combinations." Annals of Internal Medicine 154: 602-13.
8. Bognar, K., K. F. Bell, D. Lakdawalla, A. Shrestha, J. T. Snider, N. Thomas, and, D. Goldman,. 2013. " Clinical Outcomes Associated with Rates of Sulfonylurea Use among Physicians." American Journal of Managed Care 19: 16-221.
9. Bound, J., D. A. Jaeger, and, R. M. Baker,. 1995. " Problems with Instrumental Variables Estimation When the Correlation between the Instruments and the Endogenous Explanatory Variable Is Weak." Journal of American Statistical Association 90: 443-50.
10. D'Agostino, R. B., 1998. " Tutorial in Biostatistics Propensity Score Methods for Bias Reduction in the Comparison of a Treatment to a Non-Randomized Control Group." Statistics in Medicine 17: 2265-81.
11. Davidson, R., and, J. G. MacKinnon,. 1989. " Testing for Consistency Using Artificial Regressions." Econometric Theory 5 (3): 363-84.
12. Dowd, B. E., 2011. " Separated at Birth: Statisticians, Social Scientists, and Causality in Health Services Research." Health Services Research 46 (2): 397-420.
13. Doyle, J. J., S. M. Ewer, and, T. H. Wagner,. 2010. " Returns to Physician Human Capital: Evidence from Patients Randomized to Physician Teams." Journal of Health Economics 29: 866-82.
14. Edwards, S. T., J. C. Prentice, S. R. Simon, and, S. D. Pizer,. 2014. " Home-Based Primary Care and Risk of Preventable Hospitalization in Older Veterans with Diabetes." Journal of the American Medical Association Internal Medicine 174 (11): 1796-803.
15. Efron, B., 1970. " Bootstrap Methods: Another Look at the Jackknife." The Annals of Statistics 7 (1): 1-26.
16. Garabedian, L. F., P. Chu, S. Toh, A. M. Zaslavsky, and, S. B. Soumerai,. 2014. " Potential Bias of Instrumental Variable Analyses for Observational Comparative Effectiveness Research." Annals of Internal Medicine 161: 131-8.
17. Garrido, M. M., A. S. Kelley, J. Paris, K. Roza, D. E. Meier, R. S. Morrison, and, M. D. Aldridgeet,. 2014. " Methods for Constructing and Assessing Propensity Scores." Health Services Research 49 (5): 1701-20.
18. Gellad, W. F., C. B. Good, J. C. Lowe, and, J. M. Donohue,. 2010. " Variation in Prescription Use and Spending for Lipid-Lowering and Diabetes Medications in the VA Healthcare System." American Journal of Managed Care 16: 741-50.
19. Gellad, W. F., M. Mor, X. Zhao, J. Donohue, and, C. Good,. 2012. " Variation in Use of High-Cost Diabetes Medications in the VA Healthcare System." Archives of Internal Medicine 172: 1608-11.
20. Glymour, M. M., E. J. Tchetgen, and, J. M. Robins,. 2012. " Credible Mendelian Randomization Studies: Approaches for Evaluating the Instrumental Variable Assumptions." American Journal of Epidemiology 175 (4): 332-9.
21. Groop, L. C., 1992. " Sulfonylureas in NIDDM." Diabetes Care 15: 737-54.
22. Grootendorst, P., 2007. " A Review of Instrumental Variables Estimation of Treatment Effects in the Applied Health Sciences." Health Services Outcomes Research Methodology 7: 159-79.
23. Harris, K. M., and, D. K. Remler,. 1998. " Who is the Marginal Patient? Understanding Instrumental Variables Estimates of Treatment Effect." Health Services Research 33 (5 Pt 1): 1337-60.
24. Hsiao, C. J., A. K. Jha, J. King, V. Patel, M. F. Furukawa, and, F. Mostashari,. 2013a. " Office-Based Physicians Are Responding to Incentives and Assistance by Adopting and Using Electronic Health Records." Health Affairs (Millwood) 32 (8): 1470-7.
25. Hsiao, F. Y., P. H. Hsieh, W. F. Huang, Y. W. Tsai, and, C. S. Gau,. 2013b. " Risk of Bladder Cancer in Diabetic Patients Treated with Rosiglitazone or Pioglitazone: A Nested Case-Control Study." Drug Safety 36: 643-9.
26. Iezzoni, L. I., 1997. Risk Adjustment for Measuring Healthcare Outcomes. Chicago, IL: Health Administration Press.
27. Imbens, G. W., and, J. D. Angrist,. 1994. " Identification and Estimation of Local Average Treatment Effects." Econometrica 62 (2): 467-75.
28. Krumholz, H. M., 2014. " Big Data and New Knowledge in Medicine: The Thinking, Training, and Tools Needed For a Learning Health System." Health Affairs 33 (7): 1163-70.
29. Krumholz, H. M., and, J. V. Selby,. 2012. " Seeing through the Eyes of Patients: The Patient-Centered Outcomes Research Institute Funding Announcements." Annals of Internal Medicine 157 (6): 446-7.
30. Kyota, Y., S. Schneeweiss, R. J. Glynn, C. C. Cannuscio, J. Avorn, and, D. H. Solomon,. 2004. " Accuracy of Medicare Claims-Based Diagnosis of Acute Myocardial Infarction: Estimating Positive-Preidct Value on the Basis of Review of Hospital Records." American Heart Journal 148: 99-104.
31. National Research Council. 2013. Frontiers in Massive Data Analysis. Washington, DC: The National Academies Press.
32. NCQA. 2011. The State of Health Care Quality 2011. Washington, DC: National Committee for Quality Assurance.
33. Nissen, S. E., and, K. Wolski,. 2007. " Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes." New England Journal of Medicine 356: 2457-71.
34. O'Riordan, M., 2013. " Sulfonylurea Use Increases All-Cause Mortality Risk." European Association for the Study of Diabetes (EASD) 2013 Meeting. Barcelona, Spain; 201325
35. Patient-Centered Outcomes Research Institute (PCORI) Methodology Committee. 2013. " The PCORI Methodology Report " [accessed on December 27, 2013]. Available at http://www.pcori.org/research-we-support/research-methodology-standards
36. Petersen, L. A., S. Wright, S. L. T. Normand, and, J. Daley,. 1999. " Positive Predictive Value of the Diagnosis of Acute Myocardial Infarction in an Administrative Database." Journal of General Internal Medicine 14: 555-8.
37. Pizer, S. D., 2009. " An Intuitive Review of Methods for Observational Studies of Comparative Effectiveness." Health Service Outcomes Research, Methodology 9: 54-68.
38. Popper, K. R., 1959. " The Logic of Scientific Discovery, 1934." English translation 1959. New York: Basic Books, Inc.
39. Prasad, V., and, A. B. Jena,. 2013. " Prespecified Falsification End Points Can They Validate True Observational Associations? " Journal of the American Medical Association 309 (3): 241-2.
40. Prentice, J. C., P. R. Conlin, W. Gellad, D. Edelman, T. A. Lee, and, S. D. Pizer,. 2014. " Capitalizing on Prescribing Pattern Variation to Compare Medications for Type 2 Diabetes." Value in Health 17 (8): 854-62.
41. Prentice, J. C., P. R. Conlin, W. F. Gellad, D. Edelman, T. A. Lee, and, S. D. Pizer,. 2015. " Long Term Outcomes of Analogue Insulin Compared to NPH for Patients with Type 2 Diabetes." American Journal of Managed Care 21 (3): e235-44.
42. Rassen, J. A., M. A. Brookhart, R. J. Glynn, M. A. Mittleman, and, S. Schneesweiss,. 2009. " Instrumental Variables I: Instrumental Variables Exploit Natural Variation in Nonexperimental Data to Estimate Causal Relationships." Journal of Clinical Epidemiology 62 (12): 1226-32.
43. Reker, D. M., A. K. Rosen, H. Hoenig, D. R. Berlowitz, J. Laughlin, L. Anderson, C. R. Marshall, and, M. Rittman,. 2002. " The Hazards of Stroke Case Selection Using Administrative Data." Medical Care 40: 96-104.
44. Roumie, C. L., A. M. Hung, R. A. Greevy, C. G. Grijalva, X. Liu, H. J. Murff, T. A. Elasy, and, M. R. Griffin,. 2012. " Comparative Effectiveness of Sulfonylurea and Metformin Monotherapy on Cardiovascular Events in Type 2 Diabetes Mellitus: A Cohort Study." Annals of Internal Medicine 157: 601-10.
45. Rubin, D. B., 2007. " The Design versus the Analysis of Observational Studies for Causal Effects: Parallels with the Design of Randomized Trials." Statistics in Medicine 2007 (26): 20-36.
46. Selby, J. V., R. Fleurence, M. Lauer, and, S. Schneewiss,. 2012. " Reviewing Hypothetical Migraine Studies Using Funding Criteria from the Patient-Centered Outcomes Research Institute." Health Affairs 31 (10): 2193-9.
47. Stock, J. H., and, M. Yogo,. 2005. " Testing for Weak Instruments in Linear IV Regression, Chapter 5." In Identification and Inference for Econometric Models: Essays in Honor of Thomas Rothenber, edited by, D. W. K. Andrews, pp. 80-108. New York: Cambridge University Press.
48. Swanson, S. A., and, M. A. Hernán,. 2013. " How to Report Instrumental Variable Analyses (Suggestions Welcome)." Epidemiology 24 (3): 344-5.
49. Terza, J. V., A. Basu, and, P. J. Rathouz,. 2008. " Two-Stage Residual Inclusion Estimation: Addressing Endogeneity in Health Econometric Modeling." Journal of Health Economics 27 (3): 531-43.
50. The State of Health Care Quality. 2011. Continuous Improvement and the Expansion of Quality Measurement. Washington, DC: National Committee for Quality Assurance (NCQA).
51. Turner, R. C., R. R. Holman, and, C. A. Cull,. 1998. " Intensive Blood-Glucose Control with Sulphonylureas or Insulin Compared with Conventional Treatment and Risk of Complications in Patients with Type 2 Diabetes (UKPDS 33)." Lancet 352: 837-53.
52. United States General Accounting Office [US GAO]. 2010. " Drug Review Process is Standardized at the National Level, but Actions Are Needed to Ensure Timely Adjudication of Nonformulary Drug Requests." GAO 10-776 [accessed on July 31, 2014]. Available at http://www.gao.gov/assets/310/308933.pdf
53. Velentgas, P., N. A. Dreyer, P. Nourjah, S. R. Smith, and, M. M. Torchia, (eds.). 2013. Developing a Protocol for Observational Comparative Effectiveness Research: A User's Guide. AHRQ Publication No. 12(13)-EHC099. Rockville, MD: Agency for Healthcare Research and Quality.
54. Veterans Health Administration [VHA]. 2014. " About VHA " [accessed on July 15, 2014]. Available at http://www.va.gov/health/aboutvha.asp/